Bioactivity:

Sulindac is a sulfinylindene derivative prodrug with potential antineoplastic activity. Converted in vivo to an active metabolite, sulindac, a nonsteroidal anti-inflammatory drug (NSAID), blocks cyclic guanosine monophosphate-phosphodiesterase (cGMP-PDE),

CAS nr:

38194-50-2

Purity:

98%

Molecular Weight:

356,41

SMILES:

CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)=O

Formula:

C20H17FO3S

Pathway:

Immunology/Inflammation,Autophagy,Neuroscience

Target:

COX,Autophagy,COX